Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from MedAdvisor Limited ( (AU:MDR) ).
MedAdvisor Limited has announced a webinar for the presentation of its 4Q FY25 results, to be delivered by CEO Rick Ratliff and incoming CFO Sean Slattery. This event, scheduled for July 31, 2025, will provide insights into the company’s performance and future outlook, potentially impacting its operations and stakeholder interests.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.21 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Solutions is a leading company in pharmacy-driven patient engagement solutions, offering personalized experiences to simplify the medication journey. Utilizing its cloud-based, AI-enabled platform THRiV, the company enhances pharmacy workflows and patient engagement, collaborating with over 34,000 pharmacies across the US, reaching more than two-thirds of the population.
Average Trading Volume: 1,193,344
Technical Sentiment Signal: Sell
Current Market Cap: A$48.14M
For an in-depth examination of MDR stock, go to TipRanks’ Overview page.